Delivering reliable clinical trial performance across phases and therapeutic areas
For over a decade, we have partnered with global pharmaceutical companies, CROs, biotech and nutraceutical organisations as a trusted clinical trial site, delivering more than 90 studies across Phase I-IV clinical development, including pharmacokinetic and observational research.
We are an outpatient-focused, multi-therapeutic research site known for efficient study start-up, dependable enrolment and retention, and a consistently positive participant experience. Studies are typically activated in less than three months, supported by established regulatory processes and an experienced clinical research team.
Key achievements
Top recruiting site in Australia for a cardiology trial
First patient randomised in Australia for a vaccine trial
First site globally to recruit patients for a musculoskeletal trial
Accelerated 6 week startup for a vaccine trial
Our capabilities and expertise
Why partner with us
Sponsors frequently re-select our site for our consistent recruitment performance, high-quality study delivery, and strong, collaborative approach to sponsor-site partnerships. Explore the benefits of partnering with a reliable and experienced clinical research site.
Facilities and infrastructure
Located within the Gold Coast Health and Knowledge Precinct, our purpose-built facility was designed specifically for the delivery of clinical trials. With integrated infrastructure (including on-site pharmacy and lab) and access to a large, diverse participant population, our site supports operational efficiency, streamlined trial delivery, and high-quality data.
Capabilities and therapeutic areas
We deliver clinical trials across a broad range of therapeutic areas, supported by a flexible investigator network and an efficient, outpatient-focused model. Explore our capabilities and expertise across Phase I–IV studies, including pharmacokinetic and observational research.
Outstanding partner delivering rapid start-up and timely recruitment in rare diseases.
Griffith University Clinical Trial Unit has been an outstanding partner for Alexion. We achieved rapid start‑up, reached recruitment targets timely in a rare disease setting, and continue to navigate inevitable challenges together with professionalism and positivity. The Griffith team’s true patient focus, strong investigator engagement, robust operational capability, and excellent staff have all been exceptional. We look forward to continuing our partnership to bring innovative rare disease treatments to Australian patients through this site.
Leila Lotfi, Alexion Pharmaceuticals